artificial intelligence (AI)

More than 2,400 medical organizations in 75 Russian regions, together with several federal medical institutions, now have access to the platform.

The approach is intended to support drug discovery in neurology, where diseases often arise from complex interactions involving genetic, developmental, neural network, immune and environmental factors.

The collaboration combines Weave Bio’s artificial intelligence tools with Takeda’s regulatory expertise to simplify and speed up activities involved in preparing submissions and responding to questions from health authorities.

The Center provides round-the-clock support to healthcare facilities across Moscow and analyzes more than 180,000 computed tomography (CT), magnetic resonance imaging (MRI), mammography and X-ray examinations every week.

Hospitals are using these technologies in areas including mammography, stroke treatment, cancer care, sepsis detection, cardiology, neonatal services and emergency triage.

The Kingdom’s digital health market is projected to reach US$11.07 billion by 2033, highlighting growing demand for advanced healthcare technologies.

Through the expanded partnership, Mayo Clinic will clinically integrate Exer AI’s hand and wrist module into its orthopaedic workflows to support musculoskeletal care.

The AI-powered guidance will focus on building sustainable habits related to diet, physical activity, recovery and sleep, helping individuals make informed lifestyle decisions in real time.

The partnerships will enable healthcare providers to integrate wearable and out-of-hospital monitoring technologies into the Philips ecosystem.